{"symbol":"MRK","provider":"yahoo-finance","fetchedAt":"2025-12-26T04:27:23.040Z","asOfDate":"2025-12-25","articles":[{"id":"1cc2f975-ad6b-348c-b50b-60e579b6245a","title":"Dogs of the Dow Beat the Market in 2025 — Here’s the Smarter 4-Stock Play for 2026","url":"https://finance.yahoo.com/m/1cc2f975-ad6b-348c-b50b-60e579b6245a/dogs-of-the-dow-beat-the.html","publisher":"24/7 Wall St.","publishedAt":"2025-12-25T14:50:50.000Z","relatedTickers":["T","TMUS","VZ"],"mainIdea":"Dogs of the Dow Beat the Market in 2025 — Here’s the Smarter 4-Stock Play for 2026","summary":"24/7 Wall St.: Dogs of the Dow Beat the Market in 2025 — Here’s the Smarter 4-Stock Play for 2026. Keeping things simple when investing is often best, which is why buying an index fund can be the optimal strategy. Because the market has returned about 10% annually on average for the past 100 years, just buying an exchange-traded fund (ETF) could set an investor up for life. Yet you can do better than just ... Dogs of the Dow Beat the Market in 2025 — Here’s the Smarter 4-Stock Play for 2026 Related tickers mentioned: T, TMUS, VZ."},{"id":"46c4cfc2-16b2-3da0-873d-c79128c6cbec","title":"Why Merck (MRK) Outpaced the Stock Market Today","url":"https://finance.yahoo.com/news/why-merck-mrk-outpaced-stock-224503427.html","publisher":"Zacks","publishedAt":"2025-12-24T22:45:03.000Z","relatedTickers":["^DJI","^GSPC","^IXIC"],"mainIdea":"Why Merck (MRK) Outpaced the Stock Market Today","summary":"Zacks: Why Merck (MRK) Outpaced the Stock Market Today. The latest trading day saw Merck (MRK) settling at $106.45, representing a +1.34% change from its previous close. Related tickers mentioned: ^DJI, ^GSPC, ^IXIC."},{"id":"a89a21b0-4158-368a-8375-a69745a3275a","title":"PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth","url":"https://finance.yahoo.com/news/pfes-oncology-obesity-pipeline-position-162000310.html","publisher":"Zacks","publishedAt":"2025-12-24T16:20:00.000Z","relatedTickers":["JNJ","PFE"],"mainIdea":"PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth","summary":"Zacks: PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth. Pfizer faces revenue pressure from 2026-2030 LOEs but is betting on a strengthened oncology and obesity pipeline to fuel sustainable post-LOE growth. Related tickers mentioned: JNJ, PFE."},{"id":"b24a246a-6397-39aa-9b8e-de96f1593f9d","title":"Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know","url":"https://finance.yahoo.com/news/amgen-strikes-drug-pricing-deal-153300363.html","publisher":"Zacks","publishedAt":"2025-12-24T15:33:00.000Z","relatedTickers":["AMGN","BMY","GLAXF","GSK"],"mainIdea":"Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know","summary":"Zacks: Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know. AMGN signs a pricing deal with the Trump administration, cutting U.S. drug costs, expanding DTC access and securing tariff relief tied to domestic investment. Related tickers mentioned: AMGN, BMY, GLAXF, GSK."}]}
